Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)

ACCL 4.001

0.0%

11:43 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kermagoret who wrote (36)	11/11/1997 6:08:00 PM
From: John Dwyer	of 179

I'm not sure what you mean by "classical" in this sense. Many good combi-chem programs are actually hidden in other companies. Versicor is an example of this. It is a subsidiary of Sepracor and utilizes Sepracor's chiral chemistry to develop libraries. Many other companies simply have good in-house programs. There are also several good combi-chem companies that are not yet public. 3D-Pharmaceuticals is a great example. CombiChem is another interesting company although I don't follow them too closely. I don't think they are public. There are also some really cool venture cap companies that look promising. One such company is Gryphon Sciences, who utilizes non-standard amino acid side chains and non-natural peptide backbone linkages to generate very novel libraries. Molecumetics is another company utilizing peptide scaffolds. The truth is that there are only a few publicly traded pure plays in this area. Who else, NeXstar... Tripos... I probably missed a few but this should give you a start I hope this helps John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next